Dick Pound

Pound responds to allegations of drug problem in NHL

2 Comments

Dick Pound probably got a lot of interview requests in the wake of Georges Laraque’s allegations that the NHL has a performance-enhancing drug problem. The former head of the World Anti-Doping Agency (WADA) said the same thing back in 2005.

“Anybody who pays attention to these things already knew that,” Pound told the Canadian Press today. “The only organization in denial was the NHL.”

But whether or not the NHL actually does have a steroid problem still isn’t clear. With all due respect to Laraque, people have written things to sell books before. (Yeah, yeah, they said the same thing about Jose Canseco. Doesn’t make Laraque’s allegations true.)

As for Pound’s assertions, the big question is, where’s the evidence? So far all he’s provided is speculation.

From a 2007 New York Times profile of Pound:

Take the ruckus he caused when he charged that one-third of players in the National Hockey League, or about seven per team, were using illegal performance enhancers. Sitting in his office, I asked him how he came up with that estimate. He leaned back in his chair and chuckled, completely unabashed to admit that he had just invented it. “It was pick a number,” he said. “So it’s 20 percent. Twenty-five percent. Call me a liar.”

Pretty sure “call me a liar” isn’t the best way to prove serious allegations. Nor are conjectural statements like the one he made today: “When you see some of the stuff occurring on the rinks these days, you don’t know whether you’re dealing with people who are playing the game in a steroid rage or not, but some of these head shots are not accidents.”

To be fair, Pound does make a salient point about the current testing regime in the NHL.

“They still don’t test in the off-season,” he said. “If you’ve got an IQ higher than room temperature, you know they can do this program for a number of weeks and have the stuff all flushed out of your system and still get the benefit of it.

“If you know you’re not getting tested before the season begins, it’s an invitation to do it in the off-season.”

The NHL might begrudgingly agree with Pound on that point. Back in June, commissioner Gary Bettman admitted that testing could be better.

“I do believe, and we’ve been in discussions over the last couple of years with WADA, there are ways that we can improve our substance testing, our performance-enhancing testing program,” Bettman said. “But that’s something we need to do with the players’ association, and that’s something, when we actually sit down and begin discussions, we need to address.

“I think we have a good program. It deals with education and counseling. It has comprehensive testing, but I think we can probably do more. At the right time, we’ll have that discussion with the players’ association.”

The NHLPA has confirmed that performance-enhancing steroids will be addressed in the upcoming CBA negotiations.

Hopefully the players and the league can agree on a rigorous testing program, leaving no room for speculation.

Wild sign Dumba to two-year, $5.1M deal

dumbaeye
Getty Images
Leave a comment

After ongoing contract talks between the Minnesota Wild and restricted free agent defenseman Matt Dumba, the two sides have come to a deal.

The Wild announced Thursday that they had signed Dumba to a two-year deal, worth a total value of $5.1 million.

A breakdown of the new deal:

— In 2016-17: $2.35 million.

— In 2017-18: $2.75 million.

Selected seventh overall by the Wild in 2012, Dumba had his most productive campaign this past season, with 10 goals and 26 points in 81 games.

Known for his offensive skills — he had 20 goals and 57 points with Red Deer in the WHL in his draft year — Dumba also brings a coveted right-shot to the Wild blue line, which features four players with contracts of four or more years of term remaining.

As per General Fanager, the Wild still have $2.168 million in projected cap space, but they have secured all their remaining restricted free agents.

Rangers bring back forward Marek Hrivik

NEW YORK, NEW YORK - APRIL 09:  Marek Hrivik #46 of the New York Rangers skates against the Detroit Red Wings at Madison Square Garden on April 9, 2016 in New York City. The Rangers defeated the Red Wings 3-2.  (Photo by Bruce Bennett/Getty Images)
Getty Images
1 Comment

The New York Rangers announced that they’ve re-signed Marek Hrivik to a new contract. The term and financial details of the deal were not released.

Hrivik signed with the Rangers as an undrafted free agent in May 2012. The 24-year-old made his NHL debut in 2015-16 and ended up playing five games for the Rangers. He had one assist and a plus-3 rating during his time in the NHL.

The young forward was an important part of New York’s AHL affiliate in Hartford. Hrivik finished his AHL campaign with 12 goals and 29 assists. He tied for the team lead in assists and finished third in points.

If you go by Hrivik’s tweet, it appears as though he signed a one-year contract:

Now that Hrivik is re-signed, the Rangers have no more free agents of any kind, per General Fanager.

Report: Stone and Coyotes agree to one-year, $4M deal

michaelstonegetty
Getty Images
Leave a comment

Another day, another scheduled arbitration hearing avoided.

According to multiple reports, defenseman Michael Stone and the Arizona Coyotes have settled on a one-year, $4 million deal, well ahead of their scheduled arbitration hearing set for Aug. 4.

Stone, 26, was a restricted free agent coming off a three-year contract with an AAV of $1.15 million.

Last season in Arizona, he hit new career highs in points with 36 and assists with 30. He also logged some heavy minutes, playing more than 22 minutes per game, which was second behind only Oliver Ekman-Larsson. That includes being used on both the power play and penalty kill.

Just more work done for the Coyotes on Thursday.

Earlier in the day, they announced they had signed defenseman Connor Murphy to a six-year contract extension, worth a total of $23.1 million.

Related: Coyotes’ defensive makeover continues with Luke Schenn signing

‘Nothing’s different’: Dale Tallon says he still has final say in Panthers’ personnel decisions

PHILADELPHIA, PA - JUNE 28: Dale Tallon, General Manager of the Florida Panthers, speaks on the phone on Day Two of the 2014 NHL Draft at the Wells Fargo Center on June 28, 2014 in Philadelphia, Pennsylvania.  (Photo by Bruce Bennett/Getty Images)
Getty Images
Leave a comment

Despite having a terrific season in 2015-16, the Florida Panthers made a number of changes to their front office. Some of the moves include: Tom Rowe being promoted to general manager, Dale Tallon being named the director of hockey operations and Eric Joyce and Steve Werier serving as assistant general managers.

There’s a lot of confusion as to who gets to make the final call on player personnel decisions in Florida, but Tallon tried to clear that up during a radio interview with 560 WQAM on Thursday.

“It allows me to focus on what I do best,” Tallon said of the front office changes. “And that’s evaluate, travel, scout and give us information on players that will help us win a championship and keep us as a top team for the next 15 years.

“I have a lot to say. I’m a stubborn guy, I have opinions, I have strong opinions and I let them know where I stand and I let them know how I feel. That’s the way it is. The bottom line is what’s best for the team.”

When asked if he still has the final say on personnel decisions, Tallon said: “yes, I do”.

When pressed on the issue, Tallon said this:

“Like I said, it’s by committee, we do it together. We’ve always done that. Nothing’s different. We’ve got great support and things are terrific. We’re really excited about our future, we’re excited about having a chance to win this year.”

It seems curious that the Panthers made all these changes after finally having success and qualifying for the playoffs, but they appear to have strong, committed owners, who are willing to do whatever it takes to put a winning product on the ice. We’ll soon find out if the changes were for the better or not.

To listen to the full interview, click here.